Abstract
Glioblastoma (GBM) is the most aggressive malignant brain tumor. Due to the infiltration and heterogeneity of GBM, the obstruction of the blood-brain barrier (BBB) and the unique immunosuppressive mechanism, it is hard to achieve significant effects of GBM treatment. Here, a kind of chemotactic nanomotor that loaded with glucose oxidase (GOx) and carboxylated cisplatin (Pt(IV)) prodrug on the L-arginine-derived polymer is proposed. The nanomotors are driven by catalysis of glucose decomposition and the positive chemotaxis towards the GBM microenvironment where inducible nitric oxide synthase and reactive oxygen species are highly expressed. This facilitates the BBB crossing and GBM targeting of the nanomotors. In addition, the released nitric oxide (NO) during propulsion as well as the loaded GOx and Pt(IV) can exert combined NO/starvation/chemotherapy. Meanwhile, it is able to induce and enhance the immune response through multiple pathways, thus better coping with the complexities of GBM treatment.
Similar content being viewed by others
References
Barbosa BJAP, Mariano ED, Batista CM, Marie SKN, Teixeira MJ, Pereira CU, Tatagiba MS, Lepski GA. Neurosurg Rev, 2015, 38: 217–227
Jiang T, Mao Y, Ma W, Mao Q, You Y, Yang X, Jiang C, Kang C, Li X, Chen L, Qiu X, Wang W, Li W, Yao Y, Li S, Li S, Wu A, Sai K, Bai H, Li G, Chen B, Yao K, Wei X, Liu X, Zhang Z, Dai Y, Lv S, Wang L, Lin Z, Dong J, Xu G, Ma X, Cai J, Zhang W, Wang H, Chen L, Zhang C, Yang P, Yan W, Liu Z, Hu H, Chen J, Liu Y, Yang Y, Wang Z, Wang Z, Wang Y, You G, Han L, Bao Z, Liu Y, Wang Y, Fan X, Liu S, Liu X, Wang Y, Wang Q. Cancer Lett, 2016, 375: 263–273
Shergalis A, Bankhead A, Luesakul U, Muangsin N, Neamati N. Pharmacol Rev, 2018, 70: 412–445
Farooque A, Mathur R, Verma A, Kaul V, Bhatt AN, Adhikari JS, Afrin F, Singh S, Dwarakanath BS. Expert Rev Anticancer Ther, 2011, 11: 791–802
Pollycove M. Environ Health Perspect, 1998, 106: 363–368
Goellner EM, Grimme B, Brown AR, Lin YC, Wang XH, Sugrue KF, Mitchell L, Trivedi RN, Tang J, Sobol RW. Cancer Res, 2011, 71: 2308–2317
Chen J, Li Y, Yu TS, McKay RM, Burns DK, Kernie SG, Parada LF. Nature, 2012, 488: 522–526
Di Mascolo D, Palange AL, Primavera R, Macchi F, Catelani T, Piccardi F, Spanò R, Ferreira M, Marotta R, Armirotti A, Gallotti AL, Galli R, Wilson C, Grant GA, Decuzzi P. Nat Nanotechnol, 2021, 16: 820–829
Wang Y, Jiang Y, Wei D, Singh P, Yu Y, Lee T, Zhang L, Mandl HK, Piotrowski-Daspit AS, Chen X, Li F, Li X, Cheng Y, Josowitz A, Yang F, Zhao Y, Wang F, Zhao Z, Huttner A, Bindra RS, Xiao H, Mark Saltzman W. Nat Biomed Eng, 2021, 5: 1048–1058
Graham J, Muhsin M, Kirkpatrick P. Nat Rev Drug Discov, 2004, 3: 11–12
Wong DYQ, Ong WWF, Ang WH. Angew Chem Int Ed, 2015, 54: 6483–6487
Peng J, Cui Y, Xu S, Wu X, Huang Y, Zhou W, Wang S, Fu Z, Xie H. Oncol Lett, 2021, 21: 369
Fan W, Lu N, Huang P, Liu Y, Yang Z, Wang S, Yu G, Liu Y, Hu J, He Q, Qu J, Wang T, Chen X. Angew Chem Int Ed, 2017, 56: 1229–1233
Lawless SJ, Kedia-Mehta N, Walls JF, McGarrigle R, Convery O, Sinclair LV, Navarro MN, Murray J, Finlay DK. Nat Commun, 2017, 8: 15620
Tarr JM, Young PJ, Morse R, Shaw DJ, Haigh R, Petrov PG, Johnson SJ, Winyard PG, Eggleton P. J Mol Biol, 2010, 401: 799–812
Men Y, Peng S, Yang P, Jiang Q, Zhang Y, Shen B, Dong P, Pang Z, Yang W. ACS Appl Mater Interfaces, 2018, 10: 23509–23521
Kim Y, Binauld S, Stenzel MH. Biomacromolecules, 2012, 13: 3418–3426
Huang X, Huang Y. Chin Chem Lett, 2015, 26: 636–640
Liu J, Guo X, Luo Z, Zhang J, Li M, Cai K. Nanoscale, 2018, 10: 13737–13750
Shahbazi MA, Almeida PV, Mäkilä EM, Kaasalainen MH, Salonen JJ, Hirvonen JT, Santos HA. Biomaterials, 2014, 35: 7488–7500
Polzer F, Heigl J, Schneider C, Ballauff M, Borisov OV. Macromolecules, 2011, 44: 1654–1660
Fan L, Wang X, Cao Q, Yang Y, Wu D. Biomater Sci, 2019, 7: 1984–1994
Wu DQ, Zhu J, Han H, Zhang JZ, Wu FF, Qin XH, Yu JY. Acta Biomater, 2018, 65: 305–316
Sun K, Tang Y, Li Q, Yin S, Qin W, Yu J, Chiu DT, Liu Y, Yuan Z, Zhang X, Wu C. ACS Nano, 2016, 10: 6769–6781
Chang K, Liu Z, Fang X, Chen H, Men X, Yuan Y, Sun K, Zhang X, Yuan Z, Wu C. Nano Lett, 2017, 17: 4323–4329
Zhang G, Zhang L, Si Y, Li Q, Xiao J, Wang B, Liang C, Wu Z, Tian G. Chem Eng J, 2020, 388: 124269
Shi Y, Liu SA, Kerwood DJ, Goodisman J, Dabrowiak JC. J Inorg Biochem, 2012, 107: 6–14
Park SS, Jung MH, Lee YS, Bae JH, Kim SH, Ha CS. Mater Des, 2019, 184: 108187
Shen Z, Liu T, Li Y, Lau J, Yang Z, Fan W, Zhou Z, Shi C, Ke C, Bregadze VI, Mandal SK, Liu Y, Li Z, Xue T, Zhu G, Munasinghe J, Niu G, Wu A, Chen X. ACS Nano, 2018, 12: 11355–11365
Li T, Liu Z, Hu J, Chen L, Chen T, Tang Q, Yu B, Zhao B, Mao C, Wan M. Adv Mater, 2022, 34: 2206654
Ye F, Zhang B, Qiu L, Zhang Y, Zhang Y, Zhang J, Zhao Q, Lu L, Zhang Z. Mater Today Bio, 2022, 16: 100408
Chelliah SS, Paul EAL, Kamarudin MNA, Parhar I. Molecules, 2021, 26: 1169
Lin KH, Hong ST, Wang HT, Lo YL, Lin A, Yang J. Int J Mol Sci, 2016, 17: 1998
Wang Q, Li T, Yang J, Zhao Z, Tan K, Tang S, Wan M, Mao C. Adv Mater, 2022, 34: 2201406
Munger MA, Radwanski P, Hadlock GC, Stoddard G, Shaaban A, Falconer J, Grainger DW, Deering-Rice CE. Nanomed-Nanotechnol Biol Med, 2014, 10: 1–9
Yang W, Wang L, Mettenbrink EM, DeAngelis PL, Wilhelm S. Annu Rev Pharmacol Toxicol, 2021, 61: 269–289
Menges M, Roßner S, Voigtlander C, Schindler H, Kukutsch NA, Bogdan C, Erb K, Schuler G, Lutz MB. J Exp Med, 2002, 195: 15–22
Shao Q, Ning H, Lv J, Liu Y, Zhao X, Ren G, Feng A, Xie Q, Sun J, Song B, Yang Y, Gao W, Ding K, Yang M, Hou M, Peng J, Qu X. Blood, 2012, 119: 4636–4644
Bo R, Liu Z, Zhang J, Gu P, Ou N, Sun Y, Hu Y, Liu J, Wang D. Carbohydrate Polyms, 2019, 205: 540–549
Acknowledgements
This work was supported by the National Natural Science Foundation of China (22175096, 22275095), the Social Development Project of Jiangsu Natural Science Foundation (BE2019744), the Qinglan Project Foundation of Colleges and Universities of Jiangsu Province, the Jiangsu Collaborative Innovation Center of Biomedical Functional Materials, the Priority Academic Program Development of Jiangsu Higher Education Institution, the Postgraduate Research & Practice Innovation Program of Jiangsu Province (KYCX22_1545).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest The authors declare no conflict of interest.
Additional information
Supporting information The supporting information is available online at chem.scichina.com and link.springer.com/journal/11426. The supporting materials are published as submitted, without typesetting or editing. The responsibility for scientific accuracy and content remains entirely with the authors.
Supporting Information for
Rights and permissions
About this article
Cite this article
Li, T., Chen, L., Xue, Y. et al. Chemotactic nanomotor for multimodal combined therapy of glioblastoma. Sci. China Chem. 67, 1277–1288 (2024). https://doi.org/10.1007/s11426-023-1837-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11426-023-1837-7